This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Bone marrow transplant is beneficial for some rare pediatric conditions
Research Activities, March 2012, No. 379
Hematopoietic Stem-Cell Transplant (HSCT, also known as bone marrow transplant) for pediatric conditions, can be an effective treatment for Wolman's disease and Faber's disease Type 2/3, both rare fatal inherited metabolic disorders. That's the conclusion of a new research review from the Effective Health Care Program of the Agency for Healthcare Research and Quality (AHRQ). There is very limited evidence to suggest that autologous HSCT was associated with extended periods of drug- free clinical remission in a number of autoimmune diseases, including newly diagnosed type 1 juvenile diabetes and severe refractory juvenile idiopathic arthritis, systemic lupus erythematosus, systemic sclerosis, and Crohn's disease. However, the evidence is insufficient to determine the overall long-term benefits or harms of HSCT for these pediatric diseases. For the vast majority of rare pediatric diseases there is insufficient evidence to draw any conclusions about the benefit or harm of HSCT versus other approaches.
These materials and many others that explore the effectiveness and risks of treatment options for various conditions are available on AHRQ's
Effective Health Care Program
Page last reviewed March 2012
Internet Citation: Bone marrow transplant is beneficial for some rare pediatric conditions: Research Activities, March 2012, No. 379.
March 2012. Agency for Healthcare Research and Quality, Rockville, MD. https://archive.ahrq.gov/news/newsletters/research-activities/mar12/0312RA22.html
The information on this page is archived and provided for reference purposes only.